AN INTEGRATED APPROACH TO PREDICTING ONCOGENIC MUTATIONS IN NOVEL BREAST CANCER
预测新型乳腺癌致癌突变的综合方法
基本信息
- 批准号:8171895
- 负责人:
- 金额:$ 0.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAutomobile DrivingBoxingBreastCatalytic DomainComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentFundingGrantHumanIn VitroInstitutionLocationMalignant NeoplasmsMutateMutationOncogenicPIK3CA genePhosphotransferasesProtein IsoformsProteinsReportingResearchResearch PersonnelResourcesSolventsSomatic MutationSourceStructureSystemUnited States National Institutes of HealthWaterWorkgain of functionin vivoinsightmalignant breast neoplasmmolecular dynamicsnovelsimulationtumor
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Somatic mutations in PIK3CA (phosphatidylinositol-3 kinase, catalytic subunit, alpha isoform) are reported in breast and other human cancers to concentrate at hotspots within its kinase and helical domains. Most of these mutations cause kinase gain of function in vitro and are associated with oncogenicity in vivo. However, little is known about the mechanisms driving tumor development. Recent work has suggested the existence of three distinct mechanisms that produce an oncogenic PIK3CA protein depending on the structural location of the mutated residue. We propose that we can gain insight on the structural impact of oncogenic somatic mutations in PIK3CA and the existence of this multiple mechanism hypothesis by exploring conformational changes that result from these mutations using extensive molecular dynamics simulations. Our simulations will involve the PIK3CA crystal structure that contains both the PIK3CA catalytic and regulatory subunits, solvated in an explicit water solvent box resulting in the total system size of ~305063 atoms.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
据报道,PIK3CA(磷脂酰肌醇-3激酶,催化亚基,α亚型)的体细胞突变在乳腺癌和其他人类癌症中集中在其激酶和螺旋结构域的热点。这些突变中的大多数在体外都会导致激酶功能的增强,并与体内的致癌作用有关。然而,人们对驱动肿瘤发展的机制知之甚少。最近的工作表明,根据突变残基的结构位置,存在三种不同的机制来产生致癌的PIK3CA蛋白。我们认为,通过使用广泛的分子动力学模拟来探索这些突变导致的构象变化,我们可以深入了解PIK3CA致癌体细胞突变的结构影响以及这一多机制假说的存在。我们的模拟将涉及包含PIK3CA催化和调节亚基的PIK3CA晶体结构,在显式水溶剂箱中溶剂化,导致总体系尺寸为~305063个原子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachel Karchin其他文献
Rachel Karchin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachel Karchin', 18)}}的其他基金
OpenCRAVAT: Informatics Tools for High-Throughput Analysis of Cancer Mutations
OpenCRAVAT:用于癌症突变高通量分析的信息学工具
- 批准号:
10418133 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
OpenCRAVAT: Informatics Tools for High-Throughput Analysis of Cancer Mutations
OpenCRAVAT:用于癌症突变高通量分析的信息学工具
- 批准号:
10617371 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
Informatics Tools for High-throughput Analysis of Cancer Mutations
用于癌症突变高通量分析的信息学工具
- 批准号:
9094143 - 财政年份:2016
- 资助金额:
$ 0.11万 - 项目类别:
Informatics Tools for High-throughput Analysis of Cancer Mutations
用于癌症突变高通量分析的信息学工具
- 批准号:
8606625 - 财政年份:2013
- 资助金额:
$ 0.11万 - 项目类别:
Informatics Tools for High-throughput Analysis of Cancer Mutations
用于癌症突变高通量分析的信息学工具
- 批准号:
8735910 - 财政年份:2013
- 资助金额:
$ 0.11万 - 项目类别:
Tools for detecting biologically important sequence variation in cancer
用于检测癌症中具有重要生物学意义的序列变异的工具
- 批准号:
8333965 - 财政年份:2011
- 资助金额:
$ 0.11万 - 项目类别:
AN INTEGRATED APPROACH TO PREDICTING ONCOGENIC MUTATIONS IN NOVEL BREAST CANCER
预测新型乳腺癌致癌突变的综合方法
- 批准号:
8364289 - 财政年份:2011
- 资助金额:
$ 0.11万 - 项目类别:
LANGEVIN DYNAMICS SIMULATION OF LIPID KINASE MUTATIONS IN CANCER
LANGEVIN DYNAMICS 模拟癌症中的脂质激酶突变
- 批准号:
8364284 - 财政年份:2011
- 资助金额:
$ 0.11万 - 项目类别:
Tools for detecting biologically important sequence variation in cancer
用于检测癌症中具有重要生物学意义的序列变异的工具
- 批准号:
8113745 - 财政年份:2011
- 资助金额:
$ 0.11万 - 项目类别:
LANGEVIN DYNAMICS SIMULATION OF LIPID KINASE MUTATIONS IN CANCER
LANGEVIN DYNAMICS 模拟癌症中的脂质激酶突变
- 批准号:
8171866 - 财政年份:2010
- 资助金额:
$ 0.11万 - 项目类别:
相似海外基金
Establishment of a method for evaluating automobile driving ability focusing on frontal lobe functions and its application to accident prediction
以额叶功能为中心的汽车驾驶能力评价方法的建立及其在事故预测中的应用
- 批准号:
20K07947 - 财政年份:2020
- 资助金额:
$ 0.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of the Effectiveness of Multi-Professional Collaborative Assessment of Cognitive Function and Automobile Driving Skills and Comprehensive Support
认知功能与汽车驾驶技能多专业协同评估效果评价及综合支持
- 批准号:
17K19824 - 财政年份:2017
- 资助金额:
$ 0.11万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of Flexible Automobile Driving Interface for Disabled People
残疾人灵活汽车驾驶界面开发
- 批准号:
25330237 - 财政年份:2013
- 资助金额:
$ 0.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Automobile driving among older people with dementia: the effect of an intervention using a support manual for family caregivers
患有痴呆症的老年人的汽车驾驶:使用家庭护理人员支持手册进行干预的效果
- 批准号:
23591741 - 财政年份:2011
- 资助金额:
$ 0.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




